Status:
TERMINATED
Efficacy of Daylight as Adjunctive Treatment in Patients With Depression
Lead Sponsor:
University of Aarhus
Conditions:
Unipolar Depression
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
The aim of this study is to improve the treatment effect for outpatients with depression by adding regular daily morning daylight exposure to their treatment with antidepressants. Patients will wear a...
Detailed Description
Due to inadequate efficiency of existing medical and psychotherapeutic treatments for depression there is a need for investigating the efficacy of adjunctive treatments. Light therapy has proven effic...
Eligibility Criteria
Inclusion
- Fulfilling criteria for an ICD-10 diagnosis of unipolar depression (F. 32.0, F.32.1, F.32.2, F32.3, F. 32.8. F.33.0, F.33.1, F.33.2, F. 33.3)
- Hamilton Depression Score (HAM-D17) ≥ 12
- In treatment with the same antidepressant medication 14 days prior to inclusion
- The participant must have access to a smart phone
Exclusion
- Actual treatment with Electro Convulsive Therapy (ECT)
- Seasonal Affective Disorder (SAD)
- Known sleep disturbances (sleep-apnoea, narcolepsy, or "restless legs syndrome")
- On lithium, agomelatine, melatonin and/or mirtazapine
- Known eye disorders
- Current alcohol- or drug abuse
- Current user of Light therapy
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04712968
Start Date
September 1 2021
End Date
June 1 2022
Last Update
August 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
"Psykiatriens Hus" Department of Affective Disorders Arhus, University Hospital. Psychiatry
Aarhus, Denmark